Search
Burapitant
go.drugbank.com/drugs/DB20607ExperimentalBurapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1 (substance P) receptor antagonist.
Donetidine
go.drugbank.com/drugs/DB20628ExperimentalDonetidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Donetidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Tiotidine
go.drugbank.com/drugs/DB20648ExperimentalTiotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Tiotidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Mitratapide
go.drugbank.com/drugs/DB20687ExperimentalMitratapide is a small molecule drug. The usage of the INN stem '-tapide' in the name indicates that Mitratapide is a microsomal triglyceride transfer protein (MTP) inhibitor.
Salfluverine
go.drugbank.com/drugs/DB20724ExperimentalSalfluverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Salfluverine is a spasmolytic with a papaverine-like action.
Susalimod
go.drugbank.com/drugs/DB20794ExperimentalSusalimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Susalimod is a immunomodulator, both stimulant/suppressive and stimulant.
Demelverine
go.drugbank.com/drugs/DB20956ExperimentalDemelverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Demelverine is a spasmolytic with a papaverine-like action.
Synonyms: N-methyldiphenethylamineSipatrigine
go.drugbank.com/drugs/DB21032ExperimentalSipatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Sipatrigine is a sodium channel blocker, signal transduction modulator.
QRX-411
go.drugbank.com/drugs/DB17868ExperimentalIt addresses the underlying cause of Usher syndrome due to the c.7595-2144A>G mutation in the _USH2A_ gene.[L46777] … QRX-411 is a first-in-class RNA-based oligonucleotide designed to restore wild-type USH2A mRNA, leading to the production of the functional USH2A protein.
Mivebresib
go.drugbank.com/drugs/DB21300InvestigationalMivebresib is under investigation in clinical trial NCT04480086 (Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants … The usage of the INN stem '-bresib' in the name indicates that Mivebresib is a inhibitor of the bromodomain and extra-terminal motif (BET) family of bromodomain (BRD) protein, antineoplastic.